Warning Letter Roundup & Recap – July 11, 2016
This article was originally published in The Gray Sheet
QS and MDR problems noted at Zimmer's Montreal plant, and at Italian manufacturer of infusion and transfusion kits and needles. FDA released warning letters to two device companies this week.
Register for our free email digests: